Panagiotis Malandrakis

14PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersExercise physiologyHaematological tumoursMedical mycologyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 26, 2026
Efficacy and Safety of PD-1 Inhibitor-Based Regimens in Patients with Melanoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

|Feb 26, 2026
Can Exercise Training Improve the Quality of Life and Physical Function in Multiple Myeloma Patients?: Discussing the Progression of the Training Stimulus.

Polyxeni Spiliopoulou, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou

|Apr 12, 2025
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice.

Ioannis Ntanasis-Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis

|Mar 17, 2025
Current Treatment Strategies for Multiple Myeloma at First Relapse.

Evangelos Mavrothalassitis, Konstantinos Triantafyllakis, Panagiotis Malandrakis

|Feb 26, 2025
Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma.

Evangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos

|Jan 27, 2025
Increased serum B-cell maturation antigen levels evaluated with an Elecsys-based serum B-cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma.

Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis

Pageof 3

Frequent Collaborators

14 joint publications

Ioannis Ntanasis-Stathopoulos

12 joint publications

Evangelos Terpos

10 joint publications

Meletios-Athanasios Dimopoulos

9 joint publications

Efstathios Kastritis